[1]
2018. Comparison of Panretinal Photocoagulation alone With Panretinal Photocoagulation plus Intravitreal Bevacizumab in Treatment of High Risk Proliferative Diabetic Retinopathy. Journal of Fatima Jinnah Medical University. 10, 1 (Jul. 2018).